普沙托韦

普沙托韦GS-5806,化学式C24H30ClN7O3S)是一种抗病毒药,被开发用于治疗呼吸道合胞病毒感染。它作为一种融合抑制剂,在II期临床试验中显示出较好的疗效。[1][2]

普沙托韦
系统(IUPAC)命名名称
N-[2-[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide
临床数据
商品名Presatovir
合法狀態
合法状态
  • US: Investigational New Drug
识别
CAS注册号1353625-73-6
PubChemCID 58029842
化学
化学式C24H30ClN7O3S
摩尔质量532.1

参见

参考文献

  1. Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, 等. . Clinical Infectious Diseases. December 2019. PMID 31915807. doi:10.1093/cid/ciz1167.
  2. Stray K, Perron M, Porter DP, Anderson F, Lewis SA, Perry J, 等. . The Journal of Infectious Diseases. January 2020. PMID 31971597. doi:10.1093/infdis/jiaa028.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.